Nicolas de Tribolet - Concepedia

Author

Nicolas de Tribolet

Also Known As

N DE TRIBOLET, N De Tribolet, N de Tribolet, N. DE TRIBOLET, N. De Tribolet, N. Tribolet, N. de TRIBOLET, N. de Tribolet, NICOLAS DE TRIBOLET, NICOLAS de TRIBOLET

248

Publications

21.3K

Citations

H-Index

172

Concepts

All Affiliations

University Hospital of Lausanne University Hospital of Geneva University of Lausanne Ludwig Cancer Research Hôpital Orthopédique de la Suisse Romande

About

Nicolas de Tribolet is an author at University Hospital of Lausanne specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	86	7.1K
2	Health Sciences	10	10	629
3	Social Sciences	8	8	868
4	Engineering	5	5	414
5	Arts	1	1	13

Nicolas de Tribolet

136

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, New England Journal of Medicine	2005	7.1K
HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity Virginie Clément, Pilar Sánchez‐Gómez, Nicolas de Tribolet, Current Biology Lineage PlasticityDevelopmental BiologyGliomaMedicineStem Cell Research	2006	1K
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, Journal of Clinical Oncology	2002	812
Clinical Trial Substantiates the Predictive Value of <b> <i>O-6-Methylguanine-DNA Methyltransferase</i> </b> Promoter Methylation in Glioblastoma Patients Treated with Temozolomide Monika E. Hegi, Annie-Claire Diserens, Sophie Godard, Clinical Cancer Research	2004	782
Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia, Journal of Clinical Oncology	2008	728
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? Philippe Saas, Paul R. Walker, Michael Hahne, Journal of Clinical Investigation ImmunologyMaintaining Immune PrivilegeCell DeathImmune SystemImmunotherapy	1997	404
Immunosuppression and transforming growth factor-<i>beta</i> in glioblastoma. Preferential production of transforming growth factor-<i>beta</i> 2. Stefan Bodmer, KEVIN STROMMER, Karl Frei, The Journal of Immunology	1989	390
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. A. Fontana, Hans Hengartner, Nicolas de Tribolet, The Journal of Immunology Il 2T-regulatory CellImmunologyHigh-grade GliomasImmunotherapy	1984	368
Analysis of the p53 gene and its expression in human glioblastoma cells. Erwin G. Van Meir, Tetsuro Kikuchi, Mitsuhiro Tada, PubMed Human Glioblastoma CellsP53 ProteinCancer BiologyGliomaTumor Biology	1994	331
Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells Erwin G. Van Meir, Peter J. Polverini, V R Chazin, Nature Genetics Neuro-oncologyAngiogenesisGliomaMedicineVascular Biology	1994	310

Page 1